Order Online! Now! Get your $50 coupon for online order.
Order Online! Now! Get your $50 coupon for online order.
Get your basement membrane extract free sample to test now!
Get your basement membrane extract free sample to test now!
Time Limited Offer: Welcome Gift for New Customers !
Shipping Price Reduction for EU Regions
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
SMO-H52P3 | Human | Human SMO Full Length Protein (VLP) |
![]() ![]() |
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Glasdegib | PF-04; PF-4449913; PF-04449913 | Approved | Pfizer Pharmaceuticals Ltd (China) | Daurismo | United States | Leukemia, Myeloid, Acute | Pfizer Europe Ma Eeig | 2018-11-21 | Solid tumours; Hematologic Neoplasms; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Kidney Diseases; Graft vs Host Disease; Hepatic Insufficiency; Leukemia, Myeloid, Acute; Fasciitis | Details |
Vismodegib | R-3616; RG-3616; GDC-0449 | Approved | Genentech Inc, F. Hoffmann-La Roche Ltd | Erivedge | United States | Carcinoma, Basal Cell | Roche Registration Gmbh | 2012-01-30 | Gliosarcoma; Liposarcoma; Chondrosarcoma, Clear Cell; Multiple Myeloma; Neurofibrosarcoma; Sarcoma; Osteosarcoma; Sarcoma, Ewing; Breast Neoplasms; Prostatic Neoplasms; Brain Neoplasms; Basal Cell Nevus Syndrome; Colorectal Neoplasms; Sarcoma, Synovial; Gastrointestinal Stromal Tumors; Uterine Neoplasms; Leukemia, Myeloid, Acute; Carcinoma, Pancreatic Ductal; Chondrosarcoma, Mesenchymal; Lymphoma; Lymphoma, Non-Hodgkin; Sarcoma, Kaposi; Neuroectodermal Tumors, Primitive, Peripheral; Hemangioendothelioma, Epithelioid; Adenocarcinoma; Leukemia, Lymphocytic, Chronic, B-Cell; Stomach Neoplasms; Rhabdomyosarcoma; Solid tumours; Medulloblastoma; Ovarian Neoplasms; Fibrosarcoma; Chondrosarcoma; Desmoplastic Small Round Cell Tumor; Hemangiosarcoma; Carcinoma, Renal Cell; Carcinoma, Basal Cell; Mesenchymoma; Esophageal Neoplasms; Leiomyosarcoma; Ganglioglioma; Neoplasms; Pancreatic Neoplasms; Dermatofibrosarcoma; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms; Glioblastoma; Graft vs Host Disease; Skin Neo | Details |
Sonidegib Diphosphate | LDE-225; NVP-LDE-225 | Approved | Novartis Pharma Ag | Odomzo, 奥昔朵 | United States | Carcinoma, Basal Cell | Shanghai Jiyu Pharmaceutical Technology Co Ltd | 2015-07-24 | Primary Myelofibrosis; Graft vs Host Disease; Fibrosis; Skin Neoplasms; Multiple Myeloma; Thrombocytosis; Prostatic Neoplasms; Breast Neoplasms; Basal Cell Nevus Syndrome; Neuroblastoma; Bone Marrow Diseases; Glioblastoma; Colorectal Neoplasms; Astrocytoma; Hepatic Insufficiency; Carcinoma, Pancreatic Ductal; Lung Neoplasms; Leukemia, Myeloid, Acute; Glioma; Thrombocythemia, Essential; Adenocarcinoma; Carcinoma, Hepatocellular; Esophageal Neoplasms; Ovarian Neoplasms; Blood Coagulation Disorders; Bone Marrow Neoplasms; Hematologic Diseases; Hemorrhagic Disorders; Solid tumours; Leukemia, Myelogenous, Chronic; Leukemia; Rhabdomyosarcoma; Hematologic Neoplasms; Medulloblastoma; Polycythemia Vera; Carcinoma, Basal Cell; Hepatoblastoma; Stomach Neoplasms; Blood Platelet Disorders; Myeloproliferative Disorders; Pancreatic Neoplasms; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Triple Negative Breast Neoplasms | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
ZSP-1602 | ZSP-1602 | Phase 1 Clinical | Guangdong Zhongsheng Pharmaceutical Co Ltd | Medulloblastoma; Carcinoma, Basal Cell; Carcinoma; Pancreatic Neoplasms; Neoplasms; Glioblastoma; Small Cell Lung Carcinoma; Neuroendocrine Tumors; Glioma; Adenocarcinoma | Details |
Cipromedegib | SHR-1539 | Phase 1 Clinical | Jiangsu Hengrui Medicine Co Ltd | Solid tumours; Medulloblastoma; Stomach Neoplasms; Carcinoma, Basal Cell; Lung Neoplasms | Details |
GT-1708F | GT-1708F; GT-1708 | Phase 1 Clinical | Suzhou Kintor Pharmaceuticals Inc | Hematologic Neoplasms; Solid tumours | Details |
Taladegib | RXDX-109; ENV-IPF-101; ENV-ONC-101; LY-2940680; ENV-101 | Phase 2 Clinical | Eli Lilly And Company | Solid tumours; Medulloblastoma; Rhabdomyosarcoma; Esophageal Neoplasms; Idiopathic Pulmonary Fibrosis; Neoplasms; Colonic Neoplasms; Small Cell Lung Carcinoma; Cholangiocarcinoma; Sarcoma; Breast Neoplasms; Esophageal adenocarcinoma; Neoplasm Metastasis; Adenocarcinoma | Details |
This web search service is supported by Google Inc.